Related by context. All words. (Click for frequent words.) 73 mmol l 73 mg dL 72 mmol L. 71 ng mL 70 pg mL 69 g dL 69 nmol L 69 mg dl 69 ng ml 69 baseline HbA1c 68 #.#mmol L [002] 68 mmol 68 creatinine ratio 68 mEq L 67 pg ml 66 nmol liter 66 mIU L 66 μmol L 66 g dl 66 pmol L 66 diastolic BP 65 Cmax 65 mL/min/#.# m 2 65 #mg/dL [002] 65 mU L 65 ng dL 65 HbA 1c 65 lispro 65 #mg/dL [001] 65 -#.# mg dL [002] 65 hemoglobin A1c HbA1c 65 glycosylated hemoglobin HbA1c 65 alanine aminotransferase 64 umol L 64 plasma glucose levels 64 ml kg 64 serum potassium 64 mIU ml 64 highest tertile 64 nmol 64 #.#mmol L [001] 64 #ng/ml 63 creatinine clearance 63 Hb A1C 63 μg L 63 mm Hg 63 confidence interval CI 63 CrCl 63 micromoles 63 fasting glucose 63 tHcy 63 HbA1c levels 63 serum phosphorus 63 mmol liter 63 #mg/dl 63 nanograms per 63 fasting plasma glucose 63 normotensive 63 OGTT 63 HbA1c 62 #mmHg [001] 62 mmHg diastolic 62 serum concentrations 62 aspartate aminotransferase 62 mean baseline HbA1c 62 CK MB 62 log# copies mL 62 statistical significance p 62 PaO 2 62 mg d 62 μg d 62 % CI #.#-#.# [006] 62 % Confidence Interval 62 μg dL 62 serum uric acid 62 mm Hg systolic 62 HbA 1c levels 62 x ULN 62 #.#mg/dL 62 fasting plasma glucose FPG 62 intact parathyroid hormone 62 transferrin saturation 62 mU liter 62 glycated hemoglobin 62 fasting serum 62 #mmHg [002] 62 Hb A1c 62 glomerular filtration rate 61 millimoles per 61 serum urate 61 μg mL 61 nondiabetic patients 61 mmHg 61 hemoglobin Hb 61 placebo p = 61 troponin T 61 glulisine 61 atorvastatin #mg 61 P = .# 61 insulin detemir 61 serum creatinine levels 61 plasma glucose 61 confidence interval #.#-#.# 61 uM 61 mcg mL 61 NPH insulin 61 nondiabetics 61 HOMA IR 61 Fasting blood glucose 61 glycated hemoglobin levels 61 urine albumin 61 μg 61 HbA1C 61 mEq 61 microg 61 kg/m2 61 CI -#.# 61 nmol l 61 eGFR 61 triglyceride concentrations 61 creatinine 61 3mg 61 serum sodium 61 plasma folate 60 euthyroid 60 nanograms milliliter 60 lumbar spine BMD 60 aspartate aminotransferase AST 60 baseline Hb 60 glycosylated hemoglobin 60 lowest tertile 60 systolic BP 60 irbesartan 60 -#.# ± [001] 60 serum creatinine 60 MADRS score 60 fasting triglyceride levels 60 serum retinol 60 serum triglycerides 60 per deciliter mg 60 mmHg systolic 60 mL min 60 Fasting glucose 60 fructosamine 60 hypogonadal 60 Hazard Ratio HR 60 baseline serum creatinine 60 fasting insulin 60 elevated LDL cholesterol 60 oral glucose tolerance 60 fasting triglycerides 60 placebo p 60 serum IGF 60 fasting glucose levels 60 QTcF 60 μg kg 60 hydroxyvitamin D levels 60 serum phosphate 60 serum glucose 60 urinary calcium 60 milliliter ng ml 60 nM 60 fasting blood glucose 60 SGPT 60 urinary albumin 60 glycated hemoglobin HbA1c 60 mmHg p = 60 intima media thickness 60 β blockers 60 impaired fasting glucose 60 tirofiban 60 serum calcium 60 Serum creatinine 60 urinary albumin excretion 60 fasting plasma 60 serum leptin 60 IIIa inhibitors 60 sUA 59 #mg/day [002] 59 homocysteine concentrations 59 % CI #.#-#.# [001] 59 CI #.#-#.# [001] 59 p = 59 triacylglycerol concentrations 59 Hb 59 μmol 59 albuminuria 59 total cholesterol triglycerides 59 tertiles 59 alanine aminotransferase ALT 59 mcg dL 59 cTnI 59 mg TID 59 #mg/day [001] 59 nmol L. 59 mL/min/#.# m2 59 sodium excretion 59 serum phosphate levels 59 microalbuminuria 59 triacylglycerol 59 #.#mmol l [002] 59 gastric pH 59 ug kg 59 urinary excretion 59 % CI #.#-#.# [003] 59 MetS 59 CI = 59 ug ml 59 cTnT 59 diastolic blood pressures 59 serum estradiol 59 plasma leptin 59 detemir 59 creatinine levels 59 postprandial glucose 59 serum TSH 59 adiponectin concentrations 59 leukocyte count 59 elevated creatinine 59 apnea hypopnea index 59 HbA1C levels 59 statistically significant p = 59 μg liter 59 mm Hg diastolic 58 serum cortisol 58 LVEF 58 hsCRP levels 58 AUCs 58 -#.# mg dL [001] 58 #.#/#.# mmHg [001] 58 elevated ALT 58 baseline FEV 58 AUC0 58 sd = 58 MMSE score 58 SGOT 58 mol L 58 transaminases 58 ìg 58 p = .# [002] 58 PSA nadir 58 MBq 58 pg g 58 ± 58 cholesterol LDL C 58 deciliter 58 albumin excretion 58 plasma homocysteine 58 lipoprotein levels 58 plus medroxyprogesterone acetate 58 nondiabetic 58 iPTH 58 prolactin levels 58 serum PTH 58 biphasic insulin aspart 58 aminotransferases 58 mIU mL 58 colorectal adenoma 58 diastolic blood pressure 58 hypokalemia 58 tertile 58 apolipoprotein B 58 hypoglycemia 58 definite stent thrombosis 58 #mg doses [002] 58 ml min 58 serum sodium concentration 58 log# IU mL 58 #.#mmHg 58 C reactive protein 58 thyrotropin levels 58 highest quintile 58 mg kg 58 serum magnesium 58 N telopeptide 58 total cholesterol LDL 58 #μg [001] 58 serum homocysteine 58 -#.# mmol L 58 test OGTT 58 glycemia 58 serum triglyceride 58 glycaemia 58 nonobese 58 nonfasting triglyceride levels 58 P ≤ 58 hemoglobin A1C 58 LDL cholesterol concentrations 58 recurrent VTE 58 normal ULN 57 arterial oxygen saturation 57 mcg ml 57 lactate dehydrogenase LDH 57 mg kg Hematide 57 racemic albuterol 57 serum ALT 57 thiazide diuretics 57 systolic blood pressure 57 IU mL 57 μg g 57 activated partial thromboplastin 57 serum urate levels 57 statin monotherapy 57 #.#ng/ml 57 aminotransferase levels 57 CVD mortality 57 #.#mg/kg [002] 57 estimated GFR 57 elevated triglyceride levels 57 abacavir lamivudine 57 paraoxonase 57 hsCRP 57 pmol liter 57 A1c levels 57 oxycodone CR 57 rs# [002] 57 serum testosterone 57 unfractionated heparin 57 elevated blood glucose 57 serum cholesterol 57 urinary oxalate 57 severe hypoglycemic 57 nonfatal MI 57 mcg 57 density lipoprotein cholesterol 57 HDL C 57 nicardipine 57 arterial thromboembolic events 57 nonsignificant 57 mL 57 baseline A1C 57 FEV1 57 OADs 57 CC genotype 57 aPTT 57 -#.# ± [002] 57 creatine kinase 57 #mg/kg [002] 57 specific antigen PSA 57 cells uL 57 eosinophil count 57 ß = 57 plus GP IIb 57 nonfasting triglycerides 57 corrected QT interval 57 Fasting plasma glucose 57 triglyceride 57 benazepril 57 hyperlipidaemia 57 hip BMD 57 % CI #.#-#.# [004] 57 % CI #.#-#.# [002] 57 NT proBNP 57 #.#/#.# mm Hg [003] 57 aspartate 57 μg ml 57 mCi 57 hemoglobin A1c levels 57 serum insulin 57 hypoglycemic events 57 severe neutropenia 57 serum lipid 57 advanced adenoma 57 thyroxine 57 NNT = 57 kcal d 57 ng dl 57 kg m² 57 #OHD 57 cardiovascular mortality 57 serum albumin 57 #mm Hg 57 1c HbA 1c 57 mg tid 56 plasma concentrations 56 serum aminotransferase levels 56 inhibin B 56 achieved ACR# 56 neutrophil counts 56 biochemical relapse 56 URTI 56 serum selenium 56 triglyceride levels 56 rizatriptan 56 NovoLog ® Mix 56 A1c 56 nocturnal hypoglycaemia 56 elevated fasting glucose 56 oxycodone IR 56 min -1 56 UACR 56 mcg kg 56 alanine transaminase 56 nonfasting 56 REYATAZ r arm 56 #ppb [003] 56 thyroid stimulating hormone 56 severe renal impairment 56 A1C levels 56 plasma triglycerides 56 triglyceride TG 56 eNO 56 rs# [004] 56 titrated glipizide plus 56 salmeterol fluticasone propionate 56 serum calcium levels 56 COZAAR 56 budesonide pMDI 56 albumin creatinine ratio 56 BENICAR HCT 56 serum triglyceride levels 56 triiodothyronine 56 impaired glucose metabolism 56 lipoprotein Lp 56 serum ferritin 56 glomerular filtration 56 milligrams deciliter 56 proteinuria 56 D dimer 56 milligrams mg 56 mild renal insufficiency 56 Triglyceride levels 56 interleukin IL -6 56 micromolar 56 serum lipid levels 56 macroalbuminuria 56 TEAEs 56 glucose insulin 56 hemoglobin A1c 56 Plasma concentrations 56 endometrial thickness 56 Serum concentrations 56 isoprostane 56 atherogenic dyslipidemia 56 serum lactate 56 triglycerides TG 56 plasminogen activator inhibitor 56 EpCAM expression 56 fluticasone salmeterol 56 mM 56 dapagliflozin plus 56 mg kg bw 56 #.#ml [002] 56 homocysteine levels 56 #mg BID [003] 56 micrograms mcg 56 ATACAND 56 oral antidiabetic medication 56 A1C 56 hyperphenylalaninemia HPA due 56 SCr 56 ALT elevation 56 tipranavir r 56 μg l 56 MIC# [001] 56 metformin hydrochloride 56 ± SD 56 plasma lipids 56 deoxy 56 metabolite concentrations 56 ejection fractions 56 kg -1 56 mg kg dose 56 periprocedural 56 SHBG levels 56 Hazard Ratio = 56 mg orally 56 oral antidiabetes 56 hemoglobin concentrations 56 Apidra ® 56 virologic failure 56 serum CRP 56 LANTUS R 56 glucuronide 56 elevated triglycerides 56 μg dl 56 cardiac troponin T 56 hypercholesterolaemia 56 mL kg 56 mmol kg 56 nanomoles per 56 oral hypoglycemic agents 56 mg simvastatin 56 mg/# mL [002] 56 β blocker 56 mRNA expression 56 #/#mmHg 56 IIIa inhibitor 56 insulin glargine 56 confidence intervals CIs 56 postprandial insulin 56 0mg 56 thyrotropin 56 mild renal impairment 56 primary hypercholesterolemia 56 log# 56 interquartile range 56 ß carotene 56 fraction LVEF 55 serum HBV DNA 55 paricalcitol 55 overt nephropathy 55 serum prostate 55 fosamprenavir 55 myocardial infarction stroke 55 adjunctive placebo 55 antihypertensive medications 55 pCR 55 Acetate Rectal Suppositories 55 chlorthalidone 55 PREZISTA r arm 55 sitosterol 55 multivariable adjusted 55 nondepressed 55 bioavailable testosterone 55 coronary stenosis 55 C Reactive Protein 55 apnea hypopnea 55 APTIVUS r 55 triglyceride concentration 55 NHANES III 55 CHD mortality 55 lymphocyte counts 55 urinary cortisol 55 PREZISTA ritonavir 55 postintervention 55 elevated hsCRP 55 thromboembolic 55 serum folate 55 #ug [002] 55 protein excretion 55 GSTM1 55 statistically significant p 55 mcg BID 55 urinary protein 55 milliliters mL 55 PSADT 55 hypoglycemic episodes 55 pioglitazone 55 serum LDL cholesterol 55 follicle stimulating hormone FSH 55 systolic blood pressures 55 concomitant medications 55 candesartan cilexetil 55 ABCB1 55 unfractionated heparin UFH 55 left ventricular systolic 55 glucose tolerance test 55 -#.# mm Hg 55 titrated glipizide 55 p = #.# [002] 55 plasma cortisol 55 HCTZ 55 QTc interval 55 carotid IMT 55 hemoglobin concentration 55 #ppb [001] 55 angiotensin II receptor blockers 55 glimepiride 55 lipid lowering agents 55 dietary calcium intake 55 nonfatal myocardial infarction 55 echocardiographic parameters 55 albumin excretion rate 55 antibody titer 55 hypophosphatemia 55 systolic pressure 55 comparator arm 55 sulfonylurea metformin 55 -#.# log# 55 aspirin clopidogrel 55 TAXUS p value 55 lipid elevations 55 lopinavir r arm 55 LDL cholesterol levels 55 receiving ISENTRESS 55 heterozygotes 55 diastolic hypertension 55 concentration Cmax 55 cGy 55 metabolic acidosis 55 mcg QD 55 zonisamide SR 55 intramuscularly 55 HIV RNA 55 postprandial glucose PPG 55 tHcy concentrations 55 hs CRP 55 IDDM 55 nitrotyrosine 55 urinary iodine 55 serum potassium levels 55 cortisol concentrations 55 glargine 55 #OHD levels 55 Hazard Ratio 55 + PH# 55 uric acid levels 55 Hemoglobin A1C 55 isoenzyme 55 thyroid hormone levels 55 Calcium intake 55 4mg/kg 55 cTnT levels 55 transaminase 55 log# reduction 55 GnRH agonist 55 AST ALT 55 adjunctive ABILIFY 55 hours postdose 55 platelet aggregation 55 #mg [003] 55 aminotransferase elevations greater 55 recurrent UTI 55 -#.# mmHg 55 p = NS 55 prolonged QT interval 55 drank caffeinated 55 elevated serum creatinine 55 LDL C 55 HGPIN 55 sweat chloride 55 glucose concentrations 55 osmolality 55 #.#g/day 55 moderate renal impairment 55 mg calcium 55 urate lowering therapy 55 serum phosphorous 55 poor metabolizers 55 ropivacaine 55 hypertensives 55 IU ml 55 8 OHdG 54 lanthanum carbonate 54 logistic regression analysis 54 #-#,# mg 54 Pioglitazone 54 mg dose 54 mg Androxal 54 cystatin C 54 HBeAg seroconversion 54 tPSA 54 indinavir 54 milligrams 54 diuretic chlorthalidone 54 lactate dehydrogenase 54 lopinavir r 54 amprenavir 54 calcium Ca 54 mL sec 54 mg ustekinumab 54 hematological parameters 54 subclinical hyperthyroidism 54 serum PSA 54 ertapenem 54 #mg dose [003] 54 elevated uric acid 54 mEq L. 54 serum sodium levels 54 LVSD 54 hydroxyvitamin D 54 residual platelet reactivity 54 lumbar spine bone 54 valsartan 54 Januvia ® 54 TC HDL 54 HbA 1C 54 Mg Uk 54 binary restenosis 54 plasma lipid 54 gm dl 54 Lp PLA2 54 μM 54 natriuretic peptides 54 ug L 54 dehydroepiandrosterone sulfate 54 lumiracoxib 54 fetuin 54 curve AUC 54 lipid levels 54 atherogenic 54 systolic dysfunction 54 placebo 54 RBC folate 54 rs# [001] 54 EDSS score 54 blood Phe 54 p = #.# [004] 54 infliximab monotherapy 54 MMSE scores 54 preintervention 54 lipid parameters 54 aOR 54 estimated glomerular filtration 54 #mg doses [001] 54 linoleic acid LA 54 non valvular atrial 54 serum vitamin D 54 CDAI score 54 mean baseline A1C 54 hyperglycaemia 54 elevated CRP 54 cilostazol 54 carotid intima media 54 mU 54 QT intervals 54 quetiapine risperidone 54 hepatic enzymes 54 QTc intervals 54 brain natriuretic peptide 54 renal dysfunction 54 QTc 54 sFlt 1 54 gene polymorphism 54 aldosterone antagonist 54 retinol binding protein 54 #.#mg/kg [001] 54 metformin sulfonylurea 54 cholestyramine 54 thyroglobulin 54 nitroprusside 54 pravastatin therapy 54 plasma renin 54 achieved statistical significance 54 hypercapnia 54 elevated LDH 54 asymptomatic carotid stenosis 54 elevated LDL 54 dysglycemia 54 infarct size 54 flutamide 54 rs# [003] 54 seropositivity 54 8mg 54 oral allopurinol 54 aged ≥ 54 vitamin B# folic acid 54 ALT elevations 54 #ppb gold 54 hypopneas 54 serum BDNF 54 hematocrit 54 thromboembolism 54 T2DM 54 hypercholesterolemic 54 angiotensin converting enzyme 54 n = 54 acarbose 54 left ventricular dysfunction 54 phenytoin 54 baseline LDH 54 multivariate adjustment 54 postprandial glycemia 54 LDL HDL 54 anion gap 54 advanced adenomas 54 TIMP 1 54 simvastatin #mg 54 ABC/3TC 54 pulmonary capillary wedge 54 vertebral fracture 54 lipid lowering medications 54 Lantus ® 54 certolizumab 54 thyroid stimulating hormone TSH 54 arterial stiffness 54 Baseline characteristics 54 Rh + 54 metformin sulfonylureas 54 pulmonary arterial 54 μmol l 54 6mg 54 % CI #.#-#.# [007] 54 alkaline phosphatase 54 transaminase elevations 54 left ventricular hypertrophy 54 metoprolol tartrate 54 pravastatin Pravachol 54 potassium sparing diuretics 54 efavirenz EFV 54 PROCTOCORT ® Suppository Hydrocortisone 54 glyburide 54 thiazide 54 mg RDEA# 54 IGFBP 54 cytopenias 54 leukocyte counts 54 univariate analyzes 54 PUFA intake 54 abdominal circumference 54 serum lipids 54 hypertensive patients 54 serum bilirubin 54 idraparinux 54 serum GGT 54 atazanavir ritonavir 54 LS BMD 54 subclinical hypothyroidism 54 CLA supplementation 54 myocardial infarction 54 contrast induced nephropathy 54 AOR = 54 dose clopidogrel 54 hydroxymethyl coenzyme 54 lipid concentrations 54 cholesterols 54 noncardiac 54 systemic embolism 54 dysfunction LVSD 54 gliclazide 54 PREZISTA r 54 IPSS 54 cerebral infarction 54 % CI #.#-#.# [008] 54 LEXIVA r 54 Nicotinic acid 54 Homocysteine 54 loop diuretics 54 lowest quintile 54 Erythropoietic therapies may 54 acrylamide intake 54 Cystatin C 54 nonpregnant women 54 milliliter ng mL 53 platelet reactivity 53 partial thromboplastin 53 medroxyprogesterone acetate 53 bezafibrate 53 Insulin sensitivity 53 per decilitre 53 tibolone 53 Ramipril 53 lamotrigine 53 corticosteroid dose 53 preserved ejection fraction 53 reinfarction 53 microgram kg 53 fractional shortening 53 carotid artery intima media 53 eptifibatide 53 systolic diastolic 53 hypercalciuria 53 ≥ 53 copies mL 53 sulfonylurea 53 multivariable analysis 53 parous women 53 LPV r 53 flow mediated dilation 53 TT genotype 53 isoproterenol 53 diastolic pressure 53 aspirin heparin 53 gemfibrozil 53 monoamine oxidase inhibitors 53 #mg #mg #mg [003] 53 postprocedure 53 Glomerular filtration rate 53 systolic 53 dose colchicine 53 postoperative mortality 53 lymphocyte count 53 Median survival 53 mg 53 International Prostate Symptom 53 hyperuricemia 53 estrone 53 sulphonylureas 53 detectable HCV RNA 53 macrovascular events 53 nanomolar 53 IM progesterone 53 allopurinol 53 BMS p = 53 conjugated equine estrogen 53 -#.# log# copies mL 53 dobutamine 53 sUA levels 53 d dimer 53 insulin degludec 53 thiazides 53 malondialdehyde MDA 53 pooled comparator 53 detrusor 53 pmol 53 GSTP1 53 abdominal adiposity 53 angiotensin converting enzyme inhibitor 53 dizziness nausea diarrhea 53 folate vitamin B 53 hypoxemia 53 leukopenia 53 cerebrovascular events 53 CsA 53 systolic diastolic blood 53 triacylglycerols 53 pharmacologically active isomer 53 creatine phosphokinase 53 μg dose 53 deoxy D 53 folate vitamin B6 53 Triglyceride 53 DAS# [002] 53 coadministration 53 dalteparin 53 mg l 53 thromboembolic events 53 deoxyglucose 53 GSTT1 53 leuprorelin 53 abciximab 53 #-# mg dL 53 postoperative complication 53 BLLs 53 peginterferon alfa 2b 53 undetectable HBV DNA 53 RYGB 53 methacholine 53 peak VO2 53 adiponectin levels 53 â ‰ ¥ 53 polytherapy 53 IELT 53 hydrochlorothiazide HCTZ 53 5-FU/LV 53 neurodevelopmental impairment 53 incontinence episodes 53 Elitek 53 salivary cortisol 53 morphometric vertebral fractures 53 preoperative PSA 53 inflammatory biomarkers 53 tranylcypromine 53 VLDL 53 tamsulosin 53 severe hypoglycemia 53 CI #.#-#.# [002] 53 Diastolic pressure 53 HDL cholesterol concentrations 53 plasma urate 53 ARCOXIA 53 d4T 53 elevated TSH 53 lipoprotein 53 mCi kg 53 oxygen desaturation 53 lispro alone 53 univariate analysis 53 hemodilution 53 nadroparin 53 intima media thickness IMT 53 abacavir 53 LV dysfunction 53 timepoints 53 noncardiovascular mortality 53 HER2 expression 53 milligrammes 53 #.#mg [003] 53 #mg sodium [003] 53 extrapyramidal symptoms 53 beta blocker therapy 53 saline placebo 53 plasma HCV RNA 53 folic acid supplement 53 mg Lucentis 53 mg mL 53 regression coefficient 53 plus glycoprotein IIb 53 interferon alfa 2b 53 SUVmax 53 biochemical recurrence 53 HDL2 53 1mg 53 progression TTP 53 pT3 53 ALT AST 53 symptomatic intracranial hemorrhage 53 tryptase 53 primary aldosteronism 53 intracranial hemorrhage ICH 53 density lipoprotein HDL cholesterol 53 blood glucose concentrations 53 ACTOplus met 53 posttransplant 53 folate concentrations 53 Crohn Disease Activity 53 #.#/#.# mm Hg [002] 53 Hypotension 53 shorter telomere length 53 plasma renin activity 53 annualized relapse 53 hyperkalemia 53 primidone 53 antihypertensive therapy 53 ELBW infants 53 specific alkaline phosphatase 53 Hemoglobin A1c 53 LV ejection fraction